Christian W.
- Country
- Germany
- Department
- Urologie
Research Overview
- Evaluation of Pembrolizumab and Axitinib Combination Versus Sunitinib Monotherapy in First-line Treatment of Metastatic Renal Cell Carcinoma
- Phase II Multicenter Trial of Reduced Intensity Radiochemotherapy with Carboplatin, Etoposide, and Cisplatin in Stage IIA/B Seminoma
- A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma
Data & Insights
Has run more than one trial at 12 of 108 partner sites.
Specializations
Urological Oncology
The investigator specializes in treating urothelial carcinoma, with particular focus on advanced and metastatic cases. Their expertise extends to innovative therapeutic approaches for patients who cannot receive conventional cisplatin-based treatments.
- Advanced Urothelial Cancer Management
- Immunotherapy Applications
- Treatment Strategies for Cisplatin-Ineligible Patients
Kidney Cancer Treatment
The investigator focuses on developing treatments for renal cell carcinoma, including both adjuvant therapy approaches and management of metastatic disease. Their work encompasses various stages of kidney cancer, from post-surgical treatment to advanced disease management.
- Advanced Renal Cell Carcinoma
- Combination Therapy Approaches
- Post-Surgical Treatment Strategies
Testicular Cancer Research
The investigator has expertise in treating stage IIA/B seminoma, focusing on optimizing treatment protocols. Their work involves developing refined approaches to radio-chemotherapy for specific stages of testicular cancer.
- Seminoma Management
- Stage-Adapted Treatment Protocols
- Radio-chemotherapy Optimization
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.